Biogen, Sobi pledge hemophilia drug donation in developing world

May 12, 2014 6:10 AM

15 0

Biogen, Sobi pledge hemophilia drug donation in developing world

(Reuters) - Biogen Idec Inc and partner Swedish Orphan Biovitrum AB on Monday said they will donate hemophilia drugs for use in developing nations in quantities large enough to treat tens of thousands of patients over the next decade.

The potentially life-saving clotting factor medicines would be intended for use in Africa, Asia and elsewhere, where three quarters of the world's 400,000 hemophilia sufferers have limited or no access to such drugs, and where most fail to live into adulthood as a result.

Read more

To category page

Loading...